PharmaShots | Incisive News in 3 Shots

Subscribe Now

Imbruvica

PharmaShots Interview: Janssen’s Mark Wildgust Shares Insights on Imbruvica for Chronic Lymphocytic Leukemia and Darzalex for Multiple Myeloma

PharmaShots Interview: Janssen’s Mark Wildgust Shares Insights on Imbruvica for Chronic Lymphocytic Leukemia and Darzalex for Mult...

May 2, 2022

PharmaShots Interview: Janssen's Mark Wildgust along with Two Other Key Speakers Share Insights on Data Presented at ASCO 2021

PharmaShots Interview: Janssen's Mark Wildgust along with Two Other Key Speakers Share Insights on Data Presented at ASCO 2021

July 19, 2021

Janssen's Imbruvica (ibrutinib) + Rituximab Receives the EC's Marketing Authorization for Previously Untreated Patients with Chronic Lymphocytic Leukemia

Janssen's Imbruvica (ibrutinib) + Rituximab Receives the EC's Marketing Authorization for Previously Untreated Patients with Chron...

September 8, 2020

Top 20 Prescription Drugs Based on 2019 Revenue

Top 20 Prescription Drugs Based on 2019 Revenue

July 17, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us